Such mechanisms may not only be relevant to the neurodegenerative spectrum disorder described in this study and the patients with MLKL-associated late-onset Alzheimer’s disease, but also to multiple sclerosis. This evidence concerns the gene MLKL and early-onset autosomal dominant Alzheimer disease.